Nevirapine Tablet, Extended Release
Product Images NDC 0378-4890

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 0378-4890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nevirapine Extended-release Tablets, Usp 100 mg Bottle Label (Image 01)

This is a description of a medication called Nevirapine with 100mg strength, packaged in a bottle with NDC 0378-6950-77. The tablets are extended-release and should be swallowed whole, dispensed in a controlled room temperature environment. The manufacturer is Mylan Pharmaceuticals and the medication is made in India. The text includes some errors that make it difficult to understand the full context of this medication.*

FDA Label Image

Mosteller Formula (Image 02)

FDA Label Image

Nevirapine Structural Formula (Image 03)

FDA Label Image

Nevirapine Extended-release Tablets, Usp 400 mg Bottle Label (Image 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.